Celgene Corporation Announces Appointment of Dr. Alise Reicin to President, Global Clinical Development

Dr. Alise Reicin will lead mid- to late-stage drug development across Celgene’s portfolio New organizational structure enhances corporate strategy and focus on discovery, development and commercialization.